Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592461 · ClinicalTrials.gov registry record
Starting Treatment With Agonist Replacement Therapies Follow-up Study
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 877
- Enrollment target
NCT01592461: Completed study, sponsored by University of California, Los Angeles.
NCT01592461 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 877 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01592461 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 877 participants
- Enrollment target
Study Summary
The purpose of the study is to conduct a follow-up of substance abuse patients (n=1,269) about 2 to 5 years since they were originally recruited from 8 substance abuse treatment clinics (located in 5 states) to participate in a prior clinical trial study called "START" (Starting Treatment with Agonist Replacement Therapies). The START Follow-up Study will be conducted over 5 years and will involve three follow-up interviews with START participants. The specific aims of the START Follow-up Study are as follows. 1. To determine longer-term outcomes of Suboxone versus methadone treatment received in the START 2. To investigate patient and treatment factors associated with post-START treatment access, utilization, and outcomes among Suboxone and methadone patients 3. To explore other correlates of the long-term outcomes among START patients.
Primary Outcome
Opiate use over approximately ten years time period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 877 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-08 |
What the finished NCT01592461 record still lists
NCT01592461 is an observational study that tracks outcomes without assigning an intervention. The registered 877 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01592461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01592461 about?
NCT01592461 is a clinical study titled "Starting Treatment With Agonist Replacement Therapies Follow-up Study". The purpose of the study is to conduct a follow-up of substance abuse patients (n=1,269) about 2 to 5 years since they were originally recruited from 8 substance abuse treatment clinics (located in 5 states) to participate in a prior clinical trial study called "START" (Starting Treatment with Agoni...
What is the current status of trial NCT01592461?
This trial is currently completed. The enrollment target is 877 participants. The study started on 2010-09. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01592461?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia